You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
Add to Favorites
Share
Kroger to pay $110 million to resolve Kentucky lawsuit over opioid epidemic
(Reuters) - Kroger (NYSE:KR) has agreed to pay $110 million to resolve a lawsuit by the state of Kentucky alleging the supermarket chain's pharmacies helped fuel a deadly opioid epidemic by flooding its communities with hundreds of millions of doses of addictive painkillers.
The settlement was announced on Thursday by Kentucky Attorney General Russell Coleman, whose state had opted to not participate in a broader $1.4-billion deal Kroger finalized last year that resolved similar claims by 30 states as well as counties, municipalities and Native American tribes.
In a lawsuit filed in state court in February, Coleman had alleged that Kroger's more than 100 Kentucky pharmacies had been responsible for over 11% of all opioid pills dispensed in the state from 2006 to 2019, or about 444 million opioid doses.
The lawsuit alleged Kroger should have known based on the suspiciously high numbers and other red flags that the drugs were being diverted for illicit purposes, and should have taken measures to stop shipments and refuse to fill suspicious prescriptions.
Instead, Kroger continued to ship massive quantities of opioids throughout the state, failed to report suspicious orders to authorities and continued to dispense addictive drugs at "alarming" rates in Kentucky, which was hard-hit by the drug-addiction epidemic, according to the lawsuit.
"This massive grocery chain that asked for our trust and our business allowed the fire of addiction to spread across the commonwealth, leaving pain and leaving so much brokenness in its aftermath," Coleman said at a press conference.
The Cincinnati-based supermarket chain, whose $25-billion proposed merger with rival Albertsons (NYSE:ACI) was terminated after courts last month blocked the deal, did not admit wrongdoing as part of Thursday's settlement. Kroger had no immediate comment.
According to the settlement agreement, Kentucky received a substantial premium above what it would have received had it joined the earlier broader settlement with Kroger. Had it done so, Kentucky would have recovered $66.6 million.
Drug manufacturers, distributors, pharmacy operators and others have agreed to pay about $50 billion to resolve lawsuits and investigations by states and local governments over their roles in the drug-overdose epidemic.
Nearly 727,000 people in the U.S. died from opioid overdoses from 1999 to 2022, according to the U.S. Centers for Disease Control and Prevention.
Risk Warnings and Disclaimers
You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
Add to Favorites
Share
Albertsons Faces Mixed Prosects Amid Positive Plan on Savings, Soft Fiscal Q4, RBC Says
Albertsons faces a mixed outlook with a positive $1.5 billion savings plan in the next three years countered by fiscal Q4 softness, RBC Capital Markets said in a review of the company's Q3 results.
"Productivity savings will be used to offset margin pressure from mix shift headwind in the short term," RBC said Wednesday in a report. Albertsons decreased its 2024 comp guidance to 1.8% to 2% from 1.8% to 2.2% "due to industry-wide softness in F&B throughout December," the report said.
"Intra-quarter trends will be important, but the next real catalyst" is 2025 guidance, the report said. RBC expects a "ramping margin contribution from retail media, productivity and owned brands expansion, but one-time costs could delay an EBITDA recovery."
RBC increased its Q4 adjusted EPS estimate to $0.41 from $0.39 and the Q4 adjusted EBITDA estimate to $845 million from $834 million.
RBC rates Albertsons outperform with a $22 price target.
Risk Warnings and Disclaimers
You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
Add to Favorites
Share
Albertsons Price Target Maintained With a $22.00/Share by RBC Capital
You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
Add to Favorites
Share
Albertsons' Q3 Earnings Beat Estimates, Digital Sales Rise 23% Y/Y
Albertsons Companies, Inc. ACI reported third-quarter fiscal 2024 results, with the top line increasing year over year but missing the Zacks Consensus Estimate. The bottom line declined year over year but beat the consensus mark.
Despite a cautious consumer environment, ACI remains focused on its "Customers for Life" strategy, which has driven growth in digital sales, pharmacy operations and loyalty program memberships. The company is also committed to accelerating growth by enhancing digital engagement, expanding omnichannel capabilities and increasing customer value.
Albertsons’ Quarterly Performance: Key Insights
Albertsons posted adjusted quarterly earnings of 71 cents per share, which surpassed the Zacks Consensus Estimate of 66 cents. However, the bottom line declined 10.1% from 79 cents per share reported in the prior-year period.
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
Albertsons Companies, Inc. Price, Consensus and EPS Surprise
Albertsons Companies, Inc. price-consensus-eps-surprise-chart | Albertsons Companies, Inc. Quote
Net sales and other revenues of $18,774.5 million were below the Zacks Consensus Estimate of $18,796 million but rose 1.2% year over year. The year-over-year increase in the top line stemmed from a 2% increase in identical sales, with strong pharmacy sales serving as the main contributor. Digital sales grew 23%. However, the overall increase in net sales and other revenues was partially offset by a decline in fuel sales.
Loyalty membership grew 15% to reach 44.3 million in the third quarter of fiscal 2024 compared with the same period in fiscal 2023.
The gross profit of $5.2 billion increased 0.9% year over year. However, the gross margin contracted 10 basis points (bps) year over year to 27.9% compared with 28% in the third quarter of fiscal 2023.
Excluding the impacts of fuel and LIFO expenses, the gross margin rate decreased 27 bps year over year. This decline was primarily caused by robust growth in pharmacy operations, which generally have a lower gross margin rate. Gross margin was also affected by higher picking and delivery costs related to continued growth in digital sales. However, the decline was partially offset by benefits from the company’s productivity initiatives.
In the quarter, selling and administrative expenses jumped 2.4% to $4.7 billion and increased 30 bps to 25.1% as a percentage of net sales and other revenues. Excluding the impact of fuel, selling and administrative expense rate rose 6 bps year over year. This was caused by merger-related costs and higher occupancy expenses, including third-party store security services. These increases were partially offset by employee-cost efficiencies and benefits from productivity initiatives.
Adjusted EBITDA declined 3.7% year over year to $1.1 billion while adjusted EBITDA margin was 5.7%, contracted 30 bps.
ACI’s Financial Snapshot
Albertsons ended the quarter with cash and cash equivalents of $202.3 million. The company’s long-term debt and finance-lease obligations totaled $7.8 billion as of Nov. 30, 2024, while total stockholders' equity amounted to $3.4 billion.
In the first 40 weeks of fiscal 2024 ended Nov. 30, 2024, capital expenditures were $1.4 billion, caused by investments in the modernization of the store fleet and the digital and technology platforms. For fiscal 2024, capital expenditures are expected in the range of $1.8 billion to $1.9 billion.
For the third quarter of fiscal 2024, the company paid a 12 cents per share dividend on Nov. 8, 2024, to its stockholders of record as of Oct. 28, 2024.
Recently, the company raised the quarterly dividend by 25% from 12 cents to 15 cents per share. The next dividend payment is scheduled for Feb. 7, 2025, for its shareholders on record as of Jan. 24, 2025. The board also authorized a share repurchase program of up to $2 billion, including the existing authorization.
Sneak Peek Into Albertsons’ Outlook
For 2024, management now expects identical sales growth in the range of 1.8% to 2%, revised from the previous guidance of 1.8% to 2.2%.
Adjusted EBITDA is likely to be in the range of $3.95-$3.99 billion compared with $3.9-$3.98 billion projected earlier. This includes continued gains from enhanced productivity initiatives.
For fiscal 2024, adjusted EPS is envisioned in the range of $2.25-$2.31 compared with the earlier view of $2.2-$2.3 and $2.88 delivered in fiscal 2023.
Shares of this Zacks Rank #2 (Buy) company have risen 8.6% in the past three months against the industry's decline of 4.8%.
Other Stocks to Consider
Ollie’s Bargain Outlet Holdings, Inc. OLLI, operates as a retailer of brand-name merchandise in the United States which offers housewares, bed and bath, food, floor coverings, health and beauty aids, books and stationery, toys, and electronics, and other products. The company currently holds a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for Ollie's Bargain’s current financial-year sales and earnings indicates a rise of around 8.3% and 13.1%, respectively, from the year-earlier levels. OLLI delivered a trailing four-quarter earnings surprise of 5%, on average.
The Clorox Company CLX engages in the manufacture and marketing of consumer and professional products worldwide, currently carrying a Zacks Rank #2. CLX delivered a trailing four-quarter average earnings surprise of 46%.
The Zacks Consensus Estimate for Clorox’s current financial-year earnings indicates growth of 11.4% from the year-ago reported numbers.
Edgewell Personal Care Company EPC manufactures and markets personal care products worldwide. It currently carries a Zacks Rank #2. EPC delivered a trailing four-quarter earnings surprise of 86.8%, on average.
The Zacks Consensus Estimate for Edgewell Personal Care’s current financial-year sales and earnings indicates a rise of around 1.8% and 5.3%, respectively, from the year-earlier levels.
Zacks Investment Research
Risk Warnings and Disclaimers
You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
Add to Favorites
Share
Deutsche Bank Trims Price Target on Albertsons to $20 From $21, Keeps Hold Rating
Albertsons has an average rating of overweight and mean price target of $22.92, according to analysts polled by FactSet.
Risk Warnings and Disclaimers
You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
Add to Favorites
Share
Albertsons : Deutsche Bank Cuts Target Price To $20 From $21
You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.